Coronary flow and hemorrhagic complications after alteplase and streptokinase administration in patients with acute myocardial infarction
Background/Aim.Up-to-date treatment of acute myocardial infarction (AIM) has been based on as early as possible establishment of circulation in ischemic myocardium whether by the use of fibrinolythic therapy and/or urgent coronary intervention which significantly changes the destiny of patients with AMI, but also increases the risk of bleeding.The